Ginkgo Bioworks Holdings DNA
NYSE DNA
$6.75 -0.05 (-0.66%)
As of: Sep 10, 2026 · 9:55 AM EDT

Ginkgo Bioworks Holdings (DNA) Operating Income Growth (5y) (2025 - 2026)

Analysis

Ginkgo Bioworks Holdings (DNA) Operating Income Growth (5y) (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 42.38 Bn 40.30 Bn 1.44 Bn
2 Medpace Holdings 16.51 Bn 16.01 Bn 201.64 Mn
3 Charles River Laboratories International 13.16 Bn 12.97 Bn 452.07 Mn
4 Icon 12.39 Bn 11.46 Bn 479.29 Mn
5 Fortrea Holdings 1.57 Bn 1.40 Bn 139.20 Mn
6 Evotec SE 621.88 Mn 196.00 Mn -
7 Ginkgo Bioworks Holdings 419.14 Mn 334.60 Mn 18.44 Mn
8 Champions Oncology 71.79 Mn 71.79 Mn 7.03 Mn
9 MindWalk Holdings 59.83 Mn 51.55 Mn 1.82 Mn
10 VivoSim Labs 1.45 Mn 1.45 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.47%
Mar 31, 2026 -4.56%
Dec 31, 2025 -4.83%
Sep 30, 2025 -21.20%